Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has issued an update.
MicroPort CardioFlow Medtech Corp. announced a significant leadership change with the resignation of Mr. Jeffrey R Lindstrom as Executive Director and President, effective March 27, 2025, to focus on other commitments. Mr. Zhang Ruinian has been appointed as his successor, bringing over 20 years of experience in various medical fields and leadership roles in prominent companies, which may enhance the company’s strategic direction and operations.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. operates in the medical technology industry, focusing on cardiovascular devices and related medical solutions. The company is part of a larger group with subsidiaries and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 66.18%
Average Trading Volume: 3,654,845
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.65B
For an in-depth examination of 2160 stock, go to TipRanks’ Stock Analysis page.